## ITW: Illinois Tool Works Inc. - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.4% in lower entry zone (3.0-6.0%), top quartile (77th pct) cross-sectional ranking. Short-term MRS_5 (3.0%) confirms momentum alignment. Strong momentum (+6.0% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($250.78)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. This Illinois Tool Works Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday**
- Source: Benzinga | 20251216T121934 | Bearish | Relevance: 100%
- Several top Wall Street analysts have downgraded the ratings of five major companies. Illinois Tool Works (NYSE: ITW) was downgraded from Neutral to Sell by Goldman Sachs, with a price target cut to $230. Other firms like Gitlab, Zimmer Biomet, StubHub Holdings, and Atmos Energy also saw their ratings lowered by various analysts.

**2. Goldman Sachs downgrades Illinois Tool Works stock to Sell on growth concerns**
- Source: Investing.com | 20251216T100911 | Bearish | Relevance: 100%
- Goldman Sachs downgraded Illinois Tool Works (ITW) from Neutral to Sell, setting a price target of $230 due to anticipated underperformance in organic and EPS growth compared to peers. Despite past successes like margin expansion from 2012-2017, the firm expects ITW's growth to remain "tepid" with below-average EPS growth in the coming years. This outlook is despite the company's consistent dividend increases and a "GOOD" financial health rating from InvestingPro.

**3. Does Insider Buying And Record Margins Change The Bull Case For Illinois Tool Works (ITW)?**
- Source: Simply Wall Street | 20251215T183812 | Somewhat-Bullish | Relevance: 100%
- Illinois Tool Works director David Byron Smith recently purchased shares, coinciding with the company reporting record operating margins of 27.4% and strong cash generation, supported by its Enterprise Initiatives program. These events, along with reaffirmed GAAP EPS guidance, indicate management's confidence in sustaining profitability despite market challenges. The article explores how this insider buying and profitability may impact the investment narrative for ITW, noting mixed institutional sentiment and segment headwinds.

**4. Does Insider Buying And Record Margins Change The Bull Case For Illinois Tool Works (ITW)?**
- Source: Simply Wall Street | 20251215T180816 | Somewhat-Bullish | Relevance: 100%
- Illinois Tool Works director David Byron Smith recently purchased 6,709 shares, coinciding with the company reporting record 27.4% operating margins and strong cash generation. These developments, along with reaffirmed GAAP EPS guidance of US$10.40â€“US$10.50, suggest management's confidence in sustaining profitability. While insider buying and margin strength support the near-term profit story, the key challenge remains slow organic growth in several segments, which investors will watch to see if re-accelerates.

**5. Illinois Tool Works (ITW): Valuation Check After Insider Buying, Record Margins and Brighter Earnings Outlook**
- Source: Simply Wall Street | 20251214T150823 | Bullish | Relevance: 100%
- Illinois Tool Works (ITW) is gaining investor attention after an insider bought shares, coinciding with the company reporting record operating margins and strong cash generation. The stock is currently deemed 1.1% undervalued by analysts, with a consensus price target slightly above its last close. While the company exhibits steady growth and resilient margins, execution remains key due to potential pressures in automotive and construction segments.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | B of A Securiti | $255 | $220 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | B of A Securiti | up | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.11M) |
| Sells | 3 ($0.37M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.8% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.1%)
- Briar Hall Managemen: 8.9% (0.0%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 7.2% (-3.6%)
- State Street Corpora: 4.3% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +6.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.56 signals overvaluation risk, limited margin of safety. Forward P/E 22.9x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 16%, margin 19%). Analyst sentiment positive (1 raises, avg +16%).

| Metric | Value |
|--------|-------|
| Market Cap | $75.4B |
| Beta | 1.15 |
| 52W Range | $214.66 - $278.13 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.56 |
| Forward P/E | 22.9 |
| Current P/E | 24.7 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.6% to 4.4% (+6.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 77th percentile. MRS_5 at 3.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.44), confirming momentum. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.41% (CS: 77) | Strong |
| RSI_14 | 66.7 | Neutral |
| MACD Histogram | 1.44 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.043x | Above |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $258.66
- **Stop Loss:** $250.78 (3.0% risk)
- **Target:** $270.48 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 152
- **Position Value:** $39,316.32
- **Portfolio %:** 39.32%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.70 | $2.81 | +4.0% |
| 2025Q2 | $2.57 | $2.58 | +0.5% |
| 2025Q1 | $2.35 | $2.38 | +1.1% |
| 2024Q4 | $2.49 | $2.54 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*